1 Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in globocan 2012. Int J Cancer 136(5): E359-386, 2015. PMID: 25220842. DOI: 10.1002/ijc.29210
2 Detterbeck FC, Chansky K, Groome P, Bolejack V, Crowley J, Shemanski L, Kennedy C, Krasnik M, Peake M and Rami-Porta R: The iaslc lung cancer staging project: Methodology and validation used in the development of proposals for revision of the stage classification of nsclc in the forthcoming (eighth) edition of the tnm classification of lung cancer. J Thorac Oncol 11(9): 1433-1446, 2016. PMID: 27448762. DOI: 10.1016/j.jtho.2016.06.028
3 Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T and Dive C: Progress and prospects of early detection in lung cancer. Open Biol 7(9), 2017. PMID: 28878044. DOI: 10.1098/rsob.170070
4 Quail DF, Zhang G, Findlay SD, Hess DA and Postovit LM: Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway. Oncogene 33(4): 461-473, 2014. PMID: 23334323. DOI: 10.1038/onc.2012.608
5 Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber DA and Maheswaran S: Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5): 1110-1122, 2014. PMID: 25171411. DOI: 10.1016/j.cell.2014.07.013
6 Said NA and Williams ED: Growth factors in induction of epithelial-mesenchymal transition and metastasis. Cells Tissues Organs 193(1-2): 85-97, 2011. PMID: 21051862. DOI: 10.1159/000320360
7 Xu J, Lamouille S and Derynck R: Tgf-beta-induced epithelial to mesenchymal transition. Cell Res 19(2): 156-172, 2009. PMID: 19153598. DOI: 10.1038/cr.2009.5
8 Papageorgis P and Stylianopoulos T: Role of tgfbeta in regulation of the tumor microenvironment and drug delivery (review). Int J Oncol 46(3): 933-943, 2015. PMID: 25573346. DOI: 10.3892/ijo.2015.2816
9 Isaji M, Nakajoh M and Naito J: Selective inhibition of collagen accumulation by n-(3,4-dimethoxycinnamoyl)anthranilic acid (n5’) in granulation tissue. Biochem Pharmacol 36(4): 469-474, 1987. PMID: 2435288. DOI: 10.1016/0006-2952(87)90353-4
10 Suzawa H, Kikuchi S, Arai N and Koda A: The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 60(2): 91-96, 1992. PMID: 1282576. DOI: 10.1254/jjp.60.91
11 Suzawa H, Kikuchi S, Ichikawa K and Koda A: Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and pge2 from human monocytes-macrophages. Jpn J Pharmacol 60(2): 85-90, 1992. PMID: 1282575. DOI: 10.1254/jjp.60.85
12 Onn A, Isobe T, Itasaka S, Wu W, O’Reilly MS, Ki Hong W, Fidler IJ and Herbst RS: Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 9(15): 5532-5539, 2003. PMID: 14654533.
13 Pang MF, Georgoudaki AM, Lambut L, Johansson J, Tabor V, Hagikura K, Jin Y, Jansson M, Alexander JS, Nelson CM, Jakobsson L, Betsholtz C, Sund M, Karlsson MC and Fuxe J: Tgf-beta1-induced emt promotes targeted migration of breast cancer cells through the lymphatic system by the activation of ccr7/ccl21-mediated chemotaxis. Oncogene 35(6): 748-760, 2016. PMID: 25961925. DOI: 10.1038/onc.2015.133
14 Saito H, Fushida S, Harada S, Miyashita T, Oyama K, Yamaguchi T, Tsukada T, Kinoshita J, Tajima H, Ninomiya I and Ohta T: Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: Inhibition of growth and fibrosis by tranilast. Gastric Cancer, 2017. PMID: 28540637. DOI: 10.1007/s10120-017-0726-5
15 Kim TI, Lee H, Hong HK, Kim KS, Choi SI, Maeng YS and Kim EK: Inhibitory effect of tranilast on transforming growth factor-beta-induced protein in granular corneal dystrophy type 2 corneal fibroblasts. Cornea 34(8): 950-958, 2015. PMID: 26020822. DOI: 10.1097/ICO.0000000000000466
16 Zeisberg M and Neilson EG: Biomarkers for epithelialmesenchymal transitions. J Clin Invest 119(6): 1429-1437, 2009. PMID: 19487819. DOI: 10.1172/JCI36183
17 Gravdal K, Halvorsen OJ, Haukaas SA and Akslen LA: A switch from e-cadherin to n-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13(23): 7003-7011, 2007. PMID: 19487819. DOI: 10.1172/JCI36183
18 Zhao M, Mishra L and Deng CX: The role of tgf-beta/smad4 signaling in cancer. Int J Biol Sci 14(2): 111-123, 2018. PMID: 29483830. DOI: 10.7150/ijbs.23230
19 Wang Y, Chu J, Yi P, Dong W, Saultz J, Wang Y, Wang H, Scoville S, Zhang J, Wu LC, Deng Y, He X, Mundy-Bosse B, Freud AG, Wang LS, Caligiuri MA and Yu J: Smad4 promotes tgf-beta-independent nk cell homeostasis and maturation and antitumor immunity. J Clin Invest 128(11): 5123-5136, 2018. PMID: 30183689. DOI: 10.1172/JCI121227
20 Ammendola M, Leporini C, Marech I, Gadaleta CD, Scognamillo G, Sacco R, Sammarco G, De Sarro G, Russo E and Ranieri G: Targeting mast cells tryptase in tumor microenvironment: A potential antiangiogenetic strategy. Biomed Res Int 2014: 154702, 2014. PMID: 25295247. DOI: 10.1155/2014/154702 Takahashi et al: Tranilast Inhibits TGF-β1-induced EMT 3295
21 Zhao K, Zhang S, Song X, Yao Y, Zhou Y, You Q, Guo Q and Lu N: Gambogic acid suppresses cancer invasion and migration by inhibiting tgfbeta1-induced epithelial-to-mesenchymal transition. Oncotarget 8(16): 27120-27136, 2017. PMID: 28404892. DOI: 10.18632/oncotarget.15449
22 Sowa T, Menju T, Sonobe M, Nakanishi T, Shikuma K, Imamura N, Motoyama H, Hijiya K, Aoyama A, Chen F, Sato T, Kobayashi M, Yoshizawa A, Haga H, Sozu T and Date H: Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma. Cancer Med 4(12): 1853-1862, 2015. PMID: 26471868. DOI: 10.1002/cam4.556
23 Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM and Busund LT: The prognostic impact of nf-kappab p105, vimentin, e-cadherin and par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Br J Cancer 99(9): 1476-1483, 2008. PMID: 18854838. DOI: 10.1038/sj.bjc.6604713
24 Tadokoro A, Kanaji N, Liu D, Yokomise H, Haba R, Ishii T, Takagi T, Watanabe N, Kita N, Kadowaki N and Bandoh S: Vimentin regulates invasiveness and is a poor prognostic marker in non-small cell lung cancer. Anticancer Res 36(4): 1545-1551, 2016. PMID: 27069130.
25 Rogosnitzky M, Danks R and Kardash E: Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders. Anticancer Res 32: 2471-2478, 2012. PMID: 22753703.
論文の公開元へ
